Cellebrite Posts Q2 EPS of 2 Cents, Beating Expectations
Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Software Stocks · Technology
Sentiment
Neutral
Importance
7
Price
$11.91
Mkt Cap
$3.804B
52W Low
$11.02
52W High
$19.98
52W Position
8.1% above low
Off High
40% below high
Rel. Volume
1.5× avg
Market data snapshot near publication time
CLBT is trading near its 52-week low of $11.02 (8.1% above the low).
Summary
Cellebrite reported Q2 EPS of 2 cents, beating expectations, while revenue slightly missed estimates. The company's market cap is $3.8B. This is the first earnings release for the quarter, providing concrete profitability data. Traders will focus on revenue growth and guidance details in the full release.
At the time of this announcement, CLBT was trading at $11.91 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.8B. The 52-week trading range was $11.02 to $19.98. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.
Price Chart
CLBT - Latest Insights
CLBT
Aug 13, 2026, 12:52 PM EDT
Price at Filing:
$10.41
Real-time Price:
$10.69
Change:
+$0.2801 (+3%)
Market Cap:
$2.694B
CLBT
Aug 13, 2026, 7:15 AM EDT
Price at Filing:
$11.78
Real-time Price:
$10.69
Change:
-$1.09 (-9%)
Market Cap:
$2.694B
CLBT
May 14, 2026, 7:15 AM EDT
Price at Filing:
$11.60
Real-time Price:
$10.69
Change:
-$0.910 (-8%)
Market Cap:
$2.694B
CLBT
May 14, 2026, 7:07 AM EDT
Price at Filing:
$11.30
Real-time Price:
$10.69
Change:
-$0.610 (-5%)
Market Cap:
$2.694B
CLBT
Mar 02, 2026, 8:30 AM EST
Price at Filing:
$13.11
Real-time Price:
$10.69
Change:
-$2.42 (-18%)
Market Cap:
$2.694B